Related Experiment Videos
Beta 2-microglobulin: its significance and clinical usefulness
1Division of Clinical Chemistry, North Carolina Memorial Hospital, University of North Carolina, Chapel Hill 27599.
Annals of Clinical and Laboratory Science
|May 1, 1990
Summary
Beta 2-Microglobulin (beta 2M) aids in assessing kidney function and serves as a marker for various diseases. While not a definitive cancer test, it offers prognostic value in certain conditions like HIV and lymphoproliferative disorders.
Area of Science:
- Biochemistry
- Clinical Chemistry
- Immunology
Background:
- Beta 2-Microglobulin (beta 2M) is an underutilized metabolite with potential clinical applications.
- Its role in assessing renal function and as a marker for neoplastic, inflammatory, and infectious conditions is recognized.
Purpose of the Study:
- To explore the multifaceted roles of beta 2-Microglobulin (beta 2M) in clinical diagnostics.
- To evaluate its utility in renal function assessment, disease monitoring, and prognosis.
Main Methods:
- Literature review of studies investigating beta 2-Microglobulin (beta 2M).
- Analysis of its diagnostic and prognostic value across various medical conditions.
Main Results:
- Beta 2M is valuable for assessing renal function, especially in kidney transplant recipients and those with tubulointerstitial disease.
- It acts as a sensitive, though nonspecific, marker for neoplastic, inflammatory, and infectious diseases.
- While not a primary malignancy test, beta 2M shows prognostic significance in lymphoproliferative disorders, including multiple myeloma, and in HIV infection.
Conclusions:
- Beta 2-Microglobulin (beta 2M) is a versatile biomarker with established and emerging clinical applications.
- Its utility spans renal diagnostics, disease monitoring, and prognostication in specific patient cohorts.